Stockcharts has now adjusted its charts for the ex-dividend
And what a difference that makes in the graphic representation.
The dividend-adjusted 50-day line is down to $16.97 and the dividend-adjusted 200-day line is at $17.01 with Pfizer now being nicely above both of them.
RSI is up to a robust 58.4 and already approaching oversold territory for the first time in over three months.